June 10, 2026
GLP-1 Agonists and Their Potential Impact on Cancer Patients’ FDG PET-CT Scans GLP-1 receptor agonists, commonly used for managing type
Continue ReadingLandmark UK Study Unravels Cancer Diagnosis Pathway for Non-Specific Symptoms A groundbreaking study in the UK has delivered the most
Continue ReadingStudy Shows Prostate Cancer Misclassification Risks A recent study has highlighted potential issues in the classification of GG1 prostate cancer,
Continue ReadingRevolutionary Biosensor for Early Cancer Detection Scientists at the Korea Institute of Materials Science (KIMS), led by Dr. Ho Sang
Continue ReadingGaps in Colorectal Cancer Testing Lead to Missed Diagnoses For years, healthcare professionals have advocated for testing colorectal cancer tumors
Continue ReadingCancer Rates Rise: A 50-Year Perspective While advancements in medical science have improved cancer survival rates, a recent report from
Continue Reading
